These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 25226850)

  • 41. MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers.
    Lu TX; Sherrill JD; Wen T; Plassard AJ; Besse JA; Abonia JP; Franciosi JP; Putnam PE; Eby M; Martin LJ; Aronow BJ; Rothenberg ME
    J Allergy Clin Immunol; 2012 Apr; 129(4):1064-75.e9. PubMed ID: 22391115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis.
    Alexander JA; Jung KW; Arora AS; Enders F; Katzka DA; Kephardt GM; Kita H; Kryzer LA; Romero Y; Smyrk TC; Talley NJ
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):742-749.e1. PubMed ID: 22475741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial.
    Straumann A; Conus S; Grzonka P; Kita H; Kephart G; Bussmann C; Beglinger C; Smith DA; Patel J; Byrne M; Simon HU
    Gut; 2010 Jan; 59(1):21-30. PubMed ID: 19828470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia.
    Chan LJ; Tan L; Dhaliwal J; Briglia F; Clarkson C; Krishnan U
    Dis Esophagus; 2016 Aug; 29(6):563-71. PubMed ID: 25872589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis.
    Rochman M; Travers J; Miracle CE; Bedard MC; Wen T; Azouz NP; Caldwell JM; Kc K; Sherrill JD; Davis BP; Rymer JK; Kaufman KM; Aronow BJ; Rothenberg ME
    J Allergy Clin Immunol; 2017 Sep; 140(3):738-749.e3. PubMed ID: 28104354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Proton Pump Inhibitor-responsive Esophageal Eosinophilia: An Overview of Cases from One University Hospital Center].
    Ahn B; Lee DH; Lee CM; Hwang JJ; Yoon H; Shin CM; Park YS; Kim N
    Korean J Gastroenterol; 2016 Apr; 67(4):178-82. PubMed ID: 27112243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review.
    de Rooij WE; Dellon ES; Parker CE; Feagan BG; Jairath V; Ma C; Bredenoord AJ
    Drugs; 2019 Sep; 79(13):1419-1434. PubMed ID: 31352605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors.
    Gonsalves N; Yang GY; Doerfler B; Ritz S; Ditto AM; Hirano I
    Gastroenterology; 2012 Jun; 142(7):1451-9.e1; quiz e14-5. PubMed ID: 22391333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia.
    Moawad FJ; Veerappan GR; Dias JA; Baker TP; Maydonovitch CL; Wong RK
    Am J Gastroenterol; 2013 Mar; 108(3):366-72. PubMed ID: 23399553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrin αM activation and upregulation on esophageal eosinophils and periostin-mediated eosinophil survival in eosinophilic esophagitis.
    Vimalathas P; Farris A; Letner D; Deshpande V; Yajnik V; Shreffler W; Garber J
    Immunol Cell Biol; 2018 Apr; 96(4):426-438. PubMed ID: 29424023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proton-pump inhibitor-responsive esophageal eosinophilia.
    Molina-Infante J; Katzka DA
    Curr Opin Gastroenterol; 2014 Jul; 30(4):428-33. PubMed ID: 24837227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proton-pump Inhibitor Response Prediction Using Esophageal microRNAs in Children With Eosinophilic Esophagitis.
    Cañas JA; Tabares A; Barbero C; García-Sánchez D; Sastre B; Rodrigo-Muñoz JM; Mahíllo-Fernández I; Rayo A; Borrell B; Cilleruelo ML; Román E; Fernandez-Fernandez S; Gutiérrez-Junquera C; Del Pozo V
    J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):755-763. PubMed ID: 33003164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis.
    Eskian M; Khorasanizadeh M; Assa'ad AH; Rezaei N
    Clin Rev Allergy Immunol; 2018 Aug; 55(1):88-98. PubMed ID: 29234969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Budesonide Oral Suspension Significantly Improves Eosinophilic Esophagitis Histology Scoring System Results: Analyses From a 12-Week, Phase 2, Randomized, Placebo-controlled Trial.
    Collins MH; Dellon ES; Katzka DA; Hirano I; Williams J; Lan L
    Am J Surg Pathol; 2019 Nov; 43(11):1501-1509. PubMed ID: 31498177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences.
    Eluri S; Dellon ES
    Curr Opin Gastroenterol; 2015 Jul; 31(4):309-15. PubMed ID: 26039722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.
    Lucendo AJ; Arias A; De Rezende LC; Yagüe-Compadre JL; Mota-Huertas T; González-Castillo S; Cuesta RA; Tenias JM; Bellón T
    J Allergy Clin Immunol; 2011 Nov; 128(5):1037-46. PubMed ID: 21880354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient with chest pain refractory to proton pump inhibitor: report of a case of eosinophilic esophagitis.
    Avallone EV; Cassieri C; Zippi M; Pica R; Marcheggiano A; Vernia P; Corazziari ES; Paoluzi P
    Clin Ter; 2014; 165(1):e70-2. PubMed ID: 24589965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Proton Pump Inhibitor Treatment in "PPI Non-responsive" Patients with Eosinophilic Esophagitis.
    Thakkar KP; Philpott H; Lafata S; Fowler M; Keene S; Iuga A; Dellon E
    J Gastrointestin Liver Dis; 2023 Mar; 32(1):15-22. PubMed ID: 37004219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eosinophilic esophagitis: Update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE).
    de Bortoli N; Penagini R; Savarino E; Marchi S
    Dig Liver Dis; 2017 Mar; 49(3):254-260. PubMed ID: 27979389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conservative long-term treatment of children with eosinophilic esophagitis.
    Levine J; Lai J; Edelman M; Schuval SJ
    Ann Allergy Asthma Immunol; 2012 May; 108(5):363-6. PubMed ID: 22541409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.